Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer.

3a–c ), while the Telli2016 algorithm did not reach statistical significance in predicting PFS (Log-rank p = 0.11; Supplementary Fig. 3b ).

also in 111,027 other papers